Biotech Hub

AbbVie insisted its plan to end discounts for some drugs on Feb. 1 will not disrupt supplies, so long as patient claims data is provided.

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter.

While physicians of color are more likely to serve marginalized communities, medical training is an intense reenactment of the injustices that seeded marginalization in the first place.

As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a median of 4.9% on more than 450 prescription medicines, according to a new analysis.

Climate change is threatening coral-reef-associated ecosystem services and people’s well-being. Addressing direct and indirect coral reef stressors while developing pathways towards recovery and adaptations could mitigate negative impacts, especially in coastal developing countries.

Africa urgently needs to guarantee its own health security.

“The biggest collective failing has been that we’ve underestimated this microbe,” the WHO’s Mike Ryan says of SARS-CoV-2.

The study report on Natural Killer Cell Therapy states the strategic and specialized needs of enterprises and companies. The Natural Killer Cell Therapy research report performs as an ideal window into the market, explaining market segmentation, classification, industries, market dynamics,

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine.

The gut microbiome has been implicated in a variety of physiological states, but controversy over ca